Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection
NCT01735136 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2019-08-26
Summary
The investigators performed a 4-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of InSan Bamboo Salt on improvement of Helicobacter pylori infection. The investigators measured improvement of Helicobacter pylori infection parameters , including 14C-UBT(Urea breath test), and subjects' symptoms, and monitored their blood pressure.
Conditions
- Helicobacter Pylori Infection
Interventions
- DIETARY_SUPPLEMENT
-
InSan Bamboo Salt
InSan Bamboo Salt (10g/day)
- DIETARY_SUPPLEMENT
-
Placebo
Placebo (10g/day)
Sponsors & Collaborators
-
Chonbuk National University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-11-21
- Primary Completion
- 2013-07-25
- Completion
- 2013-07-25
Countries
- South Korea
Study Locations
More Related Trials
-
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
NCT02934048 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection
NCT06081712 ·Status: COMPLETED ·Phase: PHASE1
-
Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori
NCT02776371 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy Against Helicobacter Pylori
NCT05301725 ·Status: COMPLETED
-
Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection
NCT07012785 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Helicobacter Pylori Eradication and Follow-up
NCT05061732 ·Status: RECRUITING ·Phase: PHASE4
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
NCT03571230 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
NCT07167511 ·Status: COMPLETED
-
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT03658746 ·Status: COMPLETED ·Phase: PHASE4
-
Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients
NCT03297242 ·Status: UNKNOWN
-
Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets
NCT03857425 ·Status: COMPLETED ·Phase: PHASE4
-
Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
NCT02759029 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori
NCT02349685 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication
NCT04527055 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
NCT05718609 ·Status: UNKNOWN ·Phase: PHASE4
-
Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
NCT03997279 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial
NCT05586113 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effective Treatment of Oral Helicobacter Pylori With the Success Rate of Gastric Eradication
NCT01863823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
NCT07285096 ·Status: RECRUITING
-
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
NCT07139366 ·Status: RECRUITING ·Phase: PHASE4
-
Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea
NCT03665428 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy
NCT03321773 ·Status: UNKNOWN ·Phase: NA
-
Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains
NCT06687473 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
NCT02923856 ·Status: UNKNOWN ·Phase: NA